0001415889-19-000144.txt : 20190211
0001415889-19-000144.hdr.sgml : 20190211
20190211160514
ACCESSION NUMBER: 0001415889-19-000144
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190207
FILED AS OF DATE: 20190211
DATE AS OF CHANGE: 20190211
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LOUGHLIN JAMES J
CENTRAL INDEX KEY: 0001276550
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 19585386
MAIL ADDRESS:
STREET 1: DORSEY & WHITNEY LLP
STREET 2: 250 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10177
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
4
1
form4-02112019_040201.xml
X0306
4
2019-02-07
0000816284
CELGENE CORP /DE/
CELG
0001276550
LOUGHLIN JAMES J
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
true
false
false
false
Common Stock
2019-02-07
4
M
0
24666
22.47
A
62102
D
Common Stock
2019-02-07
4
S
0
23466
87.289
D
38636
D
Common Stock
1800
I
Family Trust
Stock Option (right to buy)
22.47
2019-02-07
4
M
0
24666
D
2019-06-17
Common Stock
24666
0
D
The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $87.28 to $87.30, inclusive. The reporting person undertakes to provide Celgene Corporation (the "Company"), any security holder of the Company or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
The option was fully exercisable.
The option was issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan).
/s/ Mark J. Alles, Attorney-in-Fact
2019-02-11